The cholinergic anti-inflammatory pathway

The regulation of the innate immune response is critical for controlling inflammation and for the prevention and treatment of diseases. We recently demonstrated that the efferent vagus nerve inhibits pro-inflammatory cytokine release and protects against systemic inflammation, and termed this vagal function "the cholinergic anti-inflammatory pathway." The discovery that the innate immune response is regulated partially through this neural pathway provides a new understanding of the mechanisms that control inflammation. In this review, we outline the cholinergic anti-inflammatory pathway and summarize the current insights into the mechanisms of cholinergic modulation of inflammation. We also discuss possible clinical implications of vagus nerve stimulation and cholinergic modalities in the treatment of inflammatory diseases.

[1]  K. Tracey,et al.  Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation , 2000, Autonomic Neuroscience.

[2]  K. Tracey,et al.  Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis , 2004, Nature Medicine.

[3]  R. Bucala,et al.  Protection from septic shock by neutralization of macrophage migration inhibitory factor , 2000, Nature Medicine.

[4]  J. D. Albert,et al.  Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.

[5]  D. Hommes,et al.  Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. , 2002, Gastroenterology.

[6]  P. Sawchenko,et al.  Type 1 interleukin‐1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL‐1–induced cellular activation , 1995, The Journal of comparative neurology.

[7]  P. Gross,et al.  Sensory circumventricular organs and brain homeostatic pathways , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  V. Pavlov,et al.  Neural regulators of innate immune responses and inflammation , 2004, Cellular and Molecular Life Sciences CMLS.

[9]  G. Chrousos,et al.  The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. , 2000, Pharmacological reviews.

[10]  M. Sofroniew,et al.  Serum Proteins Bypass the Blood-Brain Fluid Barriers for Extracellular Entry to the Central Nervous System , 1993, Experimental Neurology.

[11]  A. Sher,et al.  Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Tracey,et al.  HMGB1 in the immunology of sepsis (not septic shock) and arthritis. , 2004, Advances in immunology.

[13]  Masaru Sugimachi,et al.  Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats , 2003, Circulation.

[14]  K. Tracey,et al.  From mouse to man: or what have we learned about cytokine-based anti-inflammatory therapies? , 1999, Shock.

[15]  S. Maier,et al.  Subdiaphragmatic vagotomy blocks interleukin-1β-induced fever but does not reduce IL-1β levels in the circulation , 2000, Autonomic Neuroscience.

[16]  W. Banks,et al.  Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier , 1994, Journal of Neuroimmunology.

[17]  C. Feighery,et al.  Tumour necrosis factor blocking agents: a new therapeutic modality for inflammatory disorders , 2002, British journal of biomedical science.

[18]  S. Maier,et al.  Cytokine-to-brain communication: a review & analysis of alternative mechanisms. , 1995, Life sciences.

[19]  M. Herkenham,et al.  Area postrema removal abolishes stimulatory effects of intravenous interleukin-1β on hypothalamic-pituitary-adrenal axis activity and c-fos mRNA in the hypothalamic paraventricular nucleus , 1998, Brain Research Bulletin.

[20]  T. Strom,et al.  Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. , 1986, Journal of immunology.

[21]  M. Wong,et al.  Localization of interleukin 1 type I receptor mRNA in rat brain. , 1994 .

[22]  C. Miller‐Graziano,et al.  Role of elevated monocyte transforming growth factorβ (TGFβ) production in posttrauma immunosuppression , 1991, Journal of Clinical Immunology.

[23]  S. Rivest,et al.  Toll‐like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram‐negative bacterial cell wall components , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  K. Tracey,et al.  Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.

[25]  B. Aggarwal,et al.  Nuclear factor-kappaB: the enemy within. , 2004, Cancer cell.

[26]  K. Buller,et al.  Circumventricular Organs: Gateways to the Brain Role Of Circumventricular Organs In Pro‐Inflammatory Cytokine‐Induced Activation Of The Hypothalamic– Pituitary–Adrenal Axis , 2001, Clinical and experimental pharmacology & physiology.

[27]  K. Tracey,et al.  HYPOPHYSECTOMY, HIGH TUMOR NECROSIS FACTOR LEVELS, AND HEMOGLOBINEMIA IN LETHAL ENDOTOXEMIC SHOCK , 1998, Shock.

[28]  K. M. Spyer,et al.  Central regulation of autonomic functions , 1990 .

[29]  W. Banks,et al.  Blood to brain transport of interleukin links the immune and central nervous systems. , 1991, Life sciences.

[30]  C. Dinarello The role of interleukin-1 in host responses to infectious diseases. , 1992, Infectious agents and disease.

[31]  C. Saper,et al.  Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain , 1992, The Journal of comparative neurology.

[32]  R. Gilmartin,et al.  Prospective Long‐Term Study of Vagus Nerve Stimulation for the Treatment of Refractory Seizures , 2000, Epilepsia.

[33]  R. Thompson,et al.  Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. , 1991, Immunology today.

[34]  F. Dudek,et al.  Vagally evoked synaptic currents in the immature rat nucleus tractus solitarii in an intact in vitro preparation , 1998, The Journal of physiology.

[35]  R. Travagli,et al.  Brainstem pathways responsible for oesophageal control of gastric motility and tone in the rat , 1999, The Journal of physiology.

[36]  D. Altavilla,et al.  Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. , 2004, Cardiovascular research.

[37]  F. Balkwill Tumor necrosis factor or tumor promoting factor? , 2002, Cytokine & growth factor reviews.

[38]  E. Wada,et al.  In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[39]  K. Tracey,et al.  Spermine Inhibits Proinflammatory Cytokine Synthesis in Human Mononuclear Cells: A Counterregulatory Mechanism that Restrains the Immune Response , 1997, The Journal of experimental medicine.

[40]  F. Heinzel The role of IFN-gamma in the pathology of experimental endotoxemia. , 1990, Journal of immunology.

[41]  P. Szlosarek,et al.  Tumour necrosis factor α: a potential target for the therapy of solid tumours , 2003 .

[42]  R. Gamelli,et al.  PARTIAL HEPATECTOMY REDUCES THE ENDOTOXIN-INDUCED PEAK CIRCULATING LEVEL OF TUMOR NECROSIS FACTOR IN RATS , 1996, Shock.

[43]  M. Satoh,et al.  Localization of type I interleukin-1 receptor mRNA in the rat brain. , 1994, Brain research. Molecular brain research.

[44]  C. Szabó,et al.  Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system. , 1998, Biochemical pharmacology.

[45]  J. Norton,et al.  Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia , 1993, The Journal of experimental medicine.

[46]  Hong Wang,et al.  The Cholinergic Anti-inflammatory Pathway: A Missing Link in Neuroimmunomodulation , 2003, Molecular medicine.

[47]  J. Blalock,et al.  Harnessing a Neural-immune Circuit to Control Inflammation and Shock , 2002, The Journal of experimental medicine.

[48]  P. Waring,et al.  Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia. , 1994, The Journal of infectious diseases.

[49]  A. Weindl,et al.  Peering through the Windows of the Brain , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[50]  Yasuyoshi Watanabe,et al.  Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1β: a possible site of prostaglandin synthesis responsible for fever , 1996, Brain Research.

[51]  G. V. Poole,et al.  Tumor Necrosis Factor α Gene Expression in Human Peritoneal Macrophages Is Suppressed by Extra-abdominal Trauma , 1995 .

[52]  N. Birdsall,et al.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. , 1998, Pharmacological reviews.

[53]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[54]  S. Maier,et al.  Vagal immune-to-brain communication: a visceral chemosensory pathway , 2000, Autonomic Neuroscience.

[55]  Hong Wang,et al.  Spermine Inhibition of Monocyte Activation and Inflammation , 1999, Molecular medicine.

[56]  K. Tracey,et al.  CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[57]  K. Tracey,et al.  HMGB1 as a late mediator of lethal systemic inflammation. , 2001, American journal of respiratory and critical care medicine.

[58]  K. Tracey,et al.  Fetuin (α2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules , 1998 .

[59]  S. Maier,et al.  TNF-α–Induced Corticosterone Elevation But Not Serum Protein or Corticosteroid Binding Globulin Reduction Is Vagally Mediated , 1997, Brain Research Bulletin.

[60]  M. Atkins,et al.  A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[61]  K. Tracey,et al.  Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway , 2002, The Journal of experimental medicine.

[62]  L. Minutoli,et al.  Efferent Vagal Fibre Stimulation Blunts Nuclear Factor-&kgr;B Activation and Protects Against Hypovolemic Hemorrhagic Shock , 2003, Circulation.

[63]  P. Sawchenko,et al.  Evidence for an Intramedullary Prostaglandin-Dependent Mechanism in the Activation of Stress-Related Neuroendocrine Circuitry by Intravenous Interleukin-1 , 1997, The Journal of Neuroscience.

[64]  L. Moldawer,et al.  BLOCKADE OF TUMOR NECROSIS FACTOR REDUCES LIPOPOLYSACCHARIDE LETHALITY, BUT NOT THE LETHALITY OF CECAL LIGATION AND PUNCTURE , 1995, Shock.

[65]  W. Banks,et al.  Blood–Brain Barrier Permeability to Ebiratide and TNF in Acute Spinal Cord Injury , 1997, Experimental Neurology.

[66]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[67]  D. McTigue,et al.  Vagal control of digestion: Modulation by central neural and peripheral endocrine factors , 1996, Neuroscience & Biobehavioral Reviews.

[68]  W. Banks,et al.  Murine tumor necrosis factor alpha is transported from blood to brain in the mouse , 1993, Journal of Neuroimmunology.

[69]  M. Sporn,et al.  Deactivation of macrophages by transforming growth factor-β , 1988, Nature.

[70]  A. Satoskar,et al.  Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis , 1999, The Journal of experimental medicine.

[71]  A. Terano,et al.  Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats , 2005, Regulatory Peptides.

[72]  Mustafa M. Husain,et al.  Vagus nerve stimulation: a new tool for brain research and therapy∗ , 2000, Biological Psychiatry.

[73]  K. Tracey,et al.  Prevention of lethality and suppression of proinflammatory cytokines in experimental septic shock by microencapsulated CNI-1493. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[74]  S. Rivest,et al.  Effect of Acute Systemic Inflammatory Response and Cytokines on the Transcription of the Genes Encoding Cyclooxygenase Enzymes (COX‐1 and COX‐2) in the Rat Brain , 1998, Journal of neurochemistry.

[75]  H. Langstein,et al.  Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. , 1992, Journal of immunology.

[76]  S. Anker,et al.  Vagal nerve stimulation in chronic heart failure: an antiinflammatory intervention? , 2004, Circulation.

[77]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[78]  J. Lindstrom Nicotinic acetylcholine receptors in health and disease , 1997, Molecular Neurobiology.

[79]  M. Feldmann,et al.  TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases , 2003, Nature Medicine.

[80]  K. Tracey,et al.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia , 1993, Nature.

[81]  Kevin J. Tracey,et al.  The inflammatory reflex , 2002, Nature.

[82]  A. Maelicke,et al.  Choline is a Selective Agonist of α7 Nicotinic Acetylcholine Receptors in the Rat Brain Neurons , 1997, The European journal of neuroscience.

[83]  K. Tracey,et al.  Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. , 1994, Annual review of medicine.

[84]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[85]  K. Tracey,et al.  TUMOR NECROSIS FACTOR IS A BRAIN DAMAGING CYTOKINE IN CEREBRAL ISCHEMIA , 1997, Shock.

[86]  Hong Wang,et al.  Regulation of macrophage activation and inflammation by spermine: a new chapter in an old story. , 2000, Critical care medicine.

[87]  A. Korczyn,et al.  The role of neuronal nicotinic acetylcholine receptor subunits in autonomic ganglia: lessons from knockout mice , 2002, Progress in Neurobiology.

[88]  A. Kastin,et al.  Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 α across the blood-brain barrier , 1996, Journal of Neuroimmunology.

[89]  Kevin J. Tracey,et al.  Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation , 2002, Nature.